Does combined neuroleptic-electroconvulsive therapy treatment increase the likelihood of creatine phosphokinase rise?
Geizer
M
M
Ancill
R J
RJ
D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood*; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D012307:Risk Factors
D014150:Antipsychotic Agents; D003402:Creatine Kinase